283 related articles for article (PubMed ID: 31816725)
21. Development of a Sensitive and High-Throughput Assay for Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active Metabolites in Human Plasma Using Ultra-high Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry.
Sumimoto T; Nakahara R; Suzuki Y; Tanaka R; Yoshida N; Ogata M; Itoh H
Ther Drug Monit; 2022 Jun; 44(3):419-429. PubMed ID: 34469417
[TBL] [Abstract][Full Text] [Related]
22. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
Guo ZX; Wu YE; Shi HY; van den Anker J; Liang P; Zheng Y; Zhao XW; Feng R; Zhao W
J Pharm Biomed Anal; 2023 Feb; 224():115159. PubMed ID: 36442459
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
[TBL] [Abstract][Full Text] [Related]
24. Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Herbrink M; de Vries N; Rosing H; Huitema AD; Nuijen B; Schellens JH; Beijnen JH
Ther Drug Monit; 2016 Dec; 38(6):649-656. PubMed ID: 27749781
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
Tachet J; Versace F; Mercier T; Buclin T; Decosterd LA; Choong E; Girardin FR
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov; 1230():123917. PubMed ID: 37956468
[TBL] [Abstract][Full Text] [Related]
26. Volumetric absorptive microsampling as a suitable tool to monitor tyrosine kinase inhibitors.
Verougstraete N; Stove CP
J Pharm Biomed Anal; 2022 Jan; 207():114418. PubMed ID: 34655987
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
Bouchet S; Chauzit E; Ducint D; Castaing N; Canal-Raffin M; Moore N; Titier K; Molimard M
Clin Chim Acta; 2011 May; 412(11-12):1060-7. PubMed ID: 21345336
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection.
Yokoyama Y; Nozawa E; Morita M; Ishikawa E; Mori T; Sakurai M; Kikuchi T; Matsuki E; Yamazaki R; Kataoka K; Jibiki A; Kawazoe H; Suzuki S; Nakamura T
J Clin Lab Anal; 2022 Aug; 36(8):e24598. PubMed ID: 35819095
[TBL] [Abstract][Full Text] [Related]
29. High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS.
Merienne C; Rousset M; Ducint D; Castaing N; Titier K; Molimard M; Bouchet S
J Pharm Biomed Anal; 2018 Feb; 150():112-120. PubMed ID: 29220734
[TBL] [Abstract][Full Text] [Related]
30. Routine therapeutic drug monitoring of tyrosine kinase inhibitors by HPLC-UV or LC-MS/MS methods.
Miura M; Takahashi N
Drug Metab Pharmacokinet; 2016 Feb; 31(1):12-20. PubMed ID: 26732608
[TBL] [Abstract][Full Text] [Related]
31. Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
Götze L; Hegele A; Metzelder SK; Renz H; Nockher WA
Clin Chim Acta; 2012 Jan; 413(1-2):143-9. PubMed ID: 21945732
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Jia M; Wu Z; Shi W; Wang S; Huang X; Zhang M; Bao W; Bao A; Zhang P; Ding F; Xie G; Lou Y; Fan G
J Pharm Biomed Anal; 2023 May; 228():115275. PubMed ID: 36871365
[TBL] [Abstract][Full Text] [Related]
33. Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Menna P; De Grazia U; Marchesi F; Minotti G; Salvatorelli E
Chemotherapy; 2020; 65(1-2):35-41. PubMed ID: 32829325
[TBL] [Abstract][Full Text] [Related]
34. A validated UPLC-MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma.
Zeng J; Cai HL; Jiang ZP; Wang Q; Zhu Y; Xu P; Zhao XL
J Pharm Anal; 2017 Dec; 7(6):374-380. PubMed ID: 29404062
[TBL] [Abstract][Full Text] [Related]
35. A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
van Erp NP; de Wit D; Guchelaar HJ; Gelderblom H; Hessing TJ; Hartigh Jd
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():33-43. PubMed ID: 24013127
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Kralj E; Trontelj J; Pajič T; Kristl A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
[TBL] [Abstract][Full Text] [Related]
37. Isocyanate derivatization coupled with phospholipid removal microelution-solid phase extraction for the simultaneous quantification of (S)-metoprolol and (S)-α-hydroxymetoprolol in human plasma with LC-MS/MS.
Meloche M; Jutras M; St-Jean I; de Denus S; Leclair G
J Pharm Biomed Anal; 2021 Sep; 204():114263. PubMed ID: 34274593
[TBL] [Abstract][Full Text] [Related]
38. A high-throughput method for the determination of 14 UV-filters in human plasma by LC-MS/MS: Minimize interferences from proteins and phospholipids in the matrix.
Yang W; Feng J; Liang W; Nie M; Tan J; Fan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124090. PubMed ID: 38522130
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
[TBL] [Abstract][Full Text] [Related]
40. An LC-MS/MS method for rapid and sensitive high-throughput simultaneous determination of various protein kinase inhibitors in human plasma.
Abdelhameed AS; Attwa MW; Kadi AA
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27450926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
